Investigator

Serra Akar

Seluk University

Research Interests

SASerra Akar
Papers(2)
Prognostic significan…Prognostic value of s…
Collaborators(10)
Sevgi AyhanTaner TuranÖzgün CeylanBURAK ERSAKFatih KilicGunsu Kimyon Comertİrem KarOkan AytekinOSMAN TÜRKMENOzlem Moraloglu Tekin
Institutions(7)
Seluk UniversityAnkara Etlik City Hos…Ankara Bilkent City H…University Of Health …Kutahya Saglik Biliml…Ankara UniversityAnkara Yldrm Beyazt U…

Papers

Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma

Endometrioid endometrial cancer is the most common histological subtype of endometrial adenocarcinoma. In the FIGO grading scheme, both architectural and nuclear grade are taken into consideration. However, the specific impact of solid growth alone on endometrioid endometrial adenocarcinoma outcome is not well documented. We sought to assess the degree of impact of solid growth on lymphovascular space invasion (LVSI), myometrial invasion, tumor size, FIGO stage, lymph node metastasis (LNM), relapse-free survival (RFS) and disease-specific survival (DSS). Paraffin blocks of 269 patients treated for endometrioid endometrial cancer were retrospectively analyzed with morphometry for solid growth percentages. A statistically significant cut-off value of 1% solid growth was found for predicting LNM and advanced stage (III or IV), myometrial invasion and LVSI (p  75% solid growth (p  75% (p > 0.05). Although > 75% solid growth was most significantly associated with many of the adverse prognostic factors, this subset did not provide prognostic superiority in predicting adverse survival when compared to subsets within 6-75% solid growth. In conclusion, although no statistically significant difference in survival was found among subdivisions of architectural grades 2 and 3, solid growth, especially ≥ 8%, appeared to be an independent prognostic factor for survival in patients with early-stage endometrioid endometrial cancer.

30Works
2Papers
10Collaborators
PrognosisOvarian NeoplasmsEndometrial NeoplasmsCardiovascular DiseasesPeritoneal NeoplasmsUterine NeoplasmsBiomarkers, Tumor